The lack of pediatric-specific medical devices is a major issue in healthcare today. According to FDA data, despite children making up nearly a quarter of the U.S. population, only 25% of medical devices approved between 2008 and 2017 were labeled for pediatric use. This shortfall is especially critical in emergency and trauma care, where having the right equipment can mean the difference between life and death.
Children aren’t just “small adults”—they have unique anatomical and physiological needs that require specialized devices. While adults benefit from a range of advanced technologies, pediatric patients are often left with scaled-down adult devices that don’t adequately fit their bodies. In life-saving situations, where every second matters, this lack of pediatric-specific options becomes even more concerning.
The Complex Challenge of Pediatric Device Development
Developing medical devices for children involves unique clinical and practical challenges. The Institute of Medicine highlights that designing for pediatric patients goes well beyond simply creating smaller versions of adult devices; it requires an entirely different approach. A device that works perfectly for a seven-year-old might be useless for a ten-year-old. This makes development complex and expensive. The market fragments across age groups, forcing companies to validate each size range separately.
Each step needs clinical studies, regulatory reviews, and manufacturing processes. With smaller patient populations in each segment, it’s often difficult for manufacturers to justify the high development and compliance costs. The regulatory pathway for pediatric devices also includes additional safety and efficacy requirements, which raises barriers to entry in this critical area.
REBOA in Pediatric Trauma: A Critical Need
The challenges of pediatric device development become starkly apparent in trauma care, particularly in the case of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This life-saving technique, which has revolutionized adult trauma care by providing crucial hemorrhage control, highlights the critical need for pediatric-specific solutions.
Traditional REBOA devices were developed with adult anatomy in mind, utilizing catheters ranging from 7 to 14 French in diameter. However, these dimensions pose significant challenges when applied to pediatric patients. A 2021 systematic review in the Journal of Trauma and Acute Care Surgery examined 16 reported cases of pediatric REBOA use, revealing concerning complications directly related to device size mismatches.
The review highlighted several critical issues: pediatric vessels, being smaller and more delicate, face an increased risk of injury from standard catheters. Pediatric arterial walls are particularly fragile, which increases the risk of vascular damage when using adult-sized devices. Often, the risks of using these larger devices in children outweigh the possible benefits, making trauma surgeons hesitant to use techniques that might otherwise be life-saving in adult cases.
COBRA-OS®: A Possible Solution?
FrontLine Medical Technologies’ COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System) represents a significant breakthrough in possibly addressing these long-standing challenges in pediatric REBOA use. The device stands out for its potential in the application of pediatric REBOA, with several key advancements that may make it particularly suitable for younger patients.
At its core, COBRA-OS® addresses a fundamental issue – anatomical fit. At 4-French, it’s small enough for most pediatric vessels. When working with arteries just 4-6mm wide in young patients, traditional 7-14 Fr catheters present an unacceptable risk. However, dimensions are only part of the issue. In trauma care, every moment matters. COBRA-OS® reduces procedural complexity, enabling faster deployment. This efficiency is crucial when treating a critically injured child. Finally, when inflating a balloon in a pediatric patient’s aorta of unknown diameter, the Safety Shoulder Reservoir™ of the COBRA-OS® can help mitigate aortic damage with its safe overinflation ability.
Research Priorities in Pediatric REBOA
The introduction of lower-profile devices like the COBRA-OS® has opened new avenues for research in pediatric trauma care. Current evidence points to several critical areas requiring further investigation to optimize pediatric REBOA applications. Long-term outcome studies are a key priority for research in pediatric trauma care. While the theoretical benefits of lower-profile devices like the COBRA-OS® are clear, we need comprehensive data on how they perform in children. These studies should look beyond immediate success rates to include potential complications and long-term vascular health outcomes for pediatric patients undergoing REBOA procedures.
Another important area of research is the development of age-specific protocols. Tailored approaches are necessary because children’s anatomical and physiological differences vary across age groups. Researchers need to identify optimal placement techniques, inflation volumes, and occlusion times for different pediatric age ranges. It’s also essential to consider the differences in vessel sizes and blood flow patterns that come with various developmental stages.
Conclusion
As the medical device industry continues to evolve, it is important to note that we can create solutions that meet the unique needs of pediatric patients with focused effort and innovative thinking. In ERs across the country, we’re still using adult-sized equipment on kids. That’s simply not good enough. We need companies to step up, more doctors to push for change, and more regulators who understand that kids can’t keep waiting for adult tools to be modified. Our youngest patients deserve at least that much.
References:
- FDA Pediatric Medical Devices Report https://www.fda.gov/media/115027/download
- Institute of Medicine. Safe Medical Devices for Children https://nap.nationalacademies.org/read/11313/chapter/3
